Literature DB >> 15727232

Late onset multiple sclerosis: clinical characteristics, prognostic factors and differential diagnosis.

V Martinelli1, M Rodegher, L Moiola, G Comi.   

Abstract

Late onset multiple sclerosis (LOMS), defined as the first presentation of clinical symptoms in patients over 50, is not a rare phenomenon as previously thought, since the prevalence ranges between 4% and 9.6% in different studies. The course of the disease is often primary progressive and pyramidal or cerebellar involvement is observed in 60%-70% of the patients at presentation. LOMS is usually associated with a faster progression to disability compared to young adult multiple sclerosis (MS) patients. Moreover in patients over 50, MS variants and atypical forms which present a difficult diagnostic problem, may be frequently encountered. The differential diagnosis may be sometimes difficult and includes cerebro-spinal vascular syndromes, hypertension-related disorders, compressive myelopathies, primary or secondary vasculitis, metabolic diseases, degenerative and nutritional syndromes. Clinical characteristics, magnetic resonance imaging (MRI) pattern of abnormalities, evoked potential studies and cerebrospinal fluid (CSF) oligoclonal band analysis are of high diagnostic yield in LOMS patients, but expertise in interpreting their results is strongly required.

Entities:  

Mesh:

Year:  2004        PMID: 15727232     DOI: 10.1007/s10072-004-0339-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  17 in total

Review 1.  Rehabilitation interventions in multiple sclerosis: an overview.

Authors:  Serafin Beer; Fary Khan; Jürg Kesselring
Journal:  J Neurol       Date:  2012-07-08       Impact factor: 4.849

Review 2.  [Prognostic and predictively relevant factors for multiple sclerosis].

Authors:  B Tackenberg; T Schneider-Hohendorf; A Müller; J Schodrowski; H Wiendl
Journal:  Nervenarzt       Date:  2014-10       Impact factor: 1.214

3.  Ovarian aging is associated with gray matter volume and disability in women with MS.

Authors:  Jennifer S Graves; Roland G Henry; Bruce A C Cree; Geralyn Lambert-Messerlian; Ruth M Greenblatt; Emmanuelle Waubant; Marcelle I Cedars; Alyssa Zhu; Peter Bacchetti; Stephen L Hauser; Jorge R Oksenberg
Journal:  Neurology       Date:  2017-12-22       Impact factor: 9.910

4.  Telomere Length Is Associated with Disability Progression in Multiple Sclerosis.

Authors:  Kristen M Krysko; Roland G Henry; Bruce A C Cree; Jue Lin; Stacy Caillier; Adam Santaniello; Chao Zhao; Refujia Gomez; Carolyn Bevan; Dana L Smith; William Stern; Gina Kirkish; Stephen L Hauser; Jorge R Oksenberg; Jennifer S Graves
Journal:  Ann Neurol       Date:  2019-10-02       Impact factor: 10.422

5.  Late-onset MS is associated with an increased rate of reaching disability milestones.

Authors:  Mads Albrecht Andersen; Mathias Due Buron; Melinda Magyari
Journal:  J Neurol       Date:  2021-03-07       Impact factor: 4.849

6.  Fluctuating neurological symptoms in demyelinating disease mimicking an acute ischaemic stroke.

Authors:  Montserrat G Delgado; Elena Santamarta; Antonio Sáiz; Davinia Larrosa; Raquel García; Pedro Oliva
Journal:  BMJ Case Rep       Date:  2012-04-02

7.  Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population.

Authors:  Hasan Simsek; Hikmet Geckin; Nilay Padir Sensoz; Edward O List; Ahmet Arman
Journal:  J Mol Neurosci       Date:  2018-11-16       Impact factor: 3.444

8.  Cognition and disease characteristics in adult onset versus late onset multiple sclerosis.

Authors:  Rachel Butler Pagnotti; Le H Hua; Justin B Miller
Journal:  Mult Scler       Date:  2021-08-19       Impact factor: 5.855

9.  Diagnosis of coexistent neurodegenerative dementias in multiple sclerosis.

Authors:  Diana P Londoño; Kogulavadanan Arumaithurai; Eleni Constantopoulos; Michael R Basso; R Ross Reichard; Eoin P Flanagan; B Mark Keegan
Journal:  Brain Commun       Date:  2022-06-22

10.  Multiple sclerosis prevalence in the United States commercially insured population.

Authors:  Piyameth Dilokthornsakul; Robert J Valuck; Kavita V Nair; John R Corboy; Richard R Allen; Jonathan D Campbell
Journal:  Neurology       Date:  2016-02-17       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.